PRE-SALE IS LIVE

Learn More

About BlueOceanSwiss(BOV)

What problem does BlueOcean Swiss solve? (or: what human need does it satisfy?) and how exactly does it do so?

First Tokenized Medtech VC Fund

BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field. For the first time, the BlueOcean STO gives investors the possibility of buying a tradable token (BOV Token) in the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments. 5 Existing portfolio companies, This STO will allow investing in more startups in order to reach a portfolio size of 8 to 12.

How is the idea monetized? How do the token holders profit?

Token holders will be able to trade with their tokens and invest in other startups

Other Important Info

BOV token is a security token

Team

BlueOceanSwiss's team members.

Emmanuel de Watteville

Emmanuel de Watteville

General Partner and Co-Founder

Linkedin
Thomas Zehnder

Thomas Zehnder

General Partner

Linkedin
Jean-Étienne Durand

Jean-Étienne Durand

Head of Operations

Linkedin

Roadmap


 
2008 Launch of BlueOcean Ventures I
2015 Launch of the second fund, BlueOcean Ventures II
2016 BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA
2017 BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)
MAY 2018 Set up of Special STO Investment Vehicle in Singapore
JULY 2018 BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO
DECEMBER 2018 End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II
BEGINNING OF 2019 BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups
2020/2021 BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company
Read More Read Less

Quick notes

Tokenomics

Token Info

Available tokens: 84.6% Price: 1 USD = 1 BOV Soft Cap: 3 200 000 USD Hard Cap: 36 000 000 USD Buy with: ETH, BTC, USD Platform: Ethereum Location: Singapore Restricted: China, Iran, North Korea

Other Info

MVP/Prototype: Yes Escrow: No Category: Financial Services

User ratings

Rate the Profit Potential

What problem does BlueOcean Swiss solve? (or: what human need does it satisfy?) and how exactly does it do so?

First Tokenized Medtech VC Fund

BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field. For the first time, the BlueOcean STO gives investors the possibility of buying a tradable token (BOV Token) in the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments. 5 Existing portfolio companies, This STO will allow investing in more startups in order to reach a portfolio size of 8 to 12.

How is the idea monetized? How do the token holders profit?

Token holders will be able to trade with their tokens and invest in other startups

Other Important Info

BOV token is a security token

Loading ratings...

Questions & Answers

Ask a Question
Loading questions and answers...

ICO Champs investors rating

Overall Rating

 
N/A

Hype

N/A

Profit Potential

N/A

Risk

N/A